The author discusses aspects of multiple myeloma. The author is critical on the role of multiple myeloma in studying cancer biology, developing cancer treatment and improving medical outcomes among cancer patients. Furthermore, the author notes that the new information on the basic biology of multiple myeloma has contributed to the evaluation of drug efficacy.